Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 4 Tumor-Agnostic 1 Head & Neck 1 Dermatologic 1

Conditions

Melanoma 11 Uveal Melanoma 3 Lung Neoplasms 2 Breast Neoplasms 2 Neoplasms 1 Neoplasm Metastasis 1 Kidney Neoplasms 1 Disease Progression 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

pembrolizumab 36 Cyclophosphamide 24 Nivolumab 23 Ipilimumab 22 aldesleukin 19 Interleukin-2 15 fludarabine 14 Specimen Handling 12 Dacarbazine 11 fludarabine phosphate 10 Magnetic Resonance Spectroscopy 10 Temozolomide 9 Radiosurgery 9 Biopsy 9 cemiplimab 8 Paclitaxel 8 dabrafenib 5 binimetinib 5 Vemurafenib 5 Radiotherapy 5 Carboplatin 5 trametinib 4 sargramostim 4 encorafenib 4 avelumab 4 Pemetrexed 4 Leucovorin 4 Fluorouracil 4 Cisplatin 4 Bevacizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × AZD 6244 × Dermatologic × Clear all

NCT01974752 2017-01-05

SUMIT

AstraZeneca

Phase 3 Completed

152 enrolled 14 charts

Uveal Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡